Related Experiment Videos
[Sarcoma of the pulmonary artery]
M Devouassoux1, F Thivolet Béjui, E Tabone
1Service d'Anatomie et de Cytologie Pathologiques, Hôpital de la Croix-Rousse, Lyon.
Revue Des Maladies Respiratoires
|July 25, 1998
Summary
Pulmonary artery sarcomas are rare tumors with potentially multiple origins, including endothelium and smooth muscle. This study reports two angiosarcoma cases, highlighting diagnostic methods and poor prognoses for these rare vascular tumors.
Area of Science:
- Cardiovascular Pathology
- Oncology
- Surgical Pathology
Background:
- Pulmonary artery sarcomas are rare malignant tumors arising from the pulmonary artery.
- Diagnosis and treatment remain challenging due to their rarity and location.
- Understanding the origins of these tumors is crucial for accurate classification and therapeutic strategies.
Observation:
- Two cases of pulmonary artery angiosarcomas were diagnosed, one via exploratory thoracotomy and the other suspected on magnetic resonance imaging.
- Treatment involved right pneumonectomy in one case and tumor resection with adjuvant therapy for metastases in the other.
- Both patients had poor prognoses, succumbing to the disease 13 and 44 months post-surgery.
Findings:
- Histological and immunohistochemical analyses confirmed both tumors as angiosarcomas.
- Ultrastructural examination revealed endothelial differentiation in one case.
- A review of 142 cases suggests pulmonary artery sarcomas may originate from endothelium (angiosarcomas), smooth muscle (leiomyosarcomas), or myointimal cells (undifferentiated/myointimal sarcomas).
Implications:
- Pulmonary artery sarcomas represent a heterogeneous group of tumors with diverse origins.
- Early and accurate diagnosis, potentially aided by advanced imaging and histology, is critical.
- The poor prognosis underscores the need for further research into effective therapeutic interventions for these rare vascular malignancies.